Peptide & Metabolic Research News
Headlines curated from respected outlets — Reuters, AP, STAT, Nature, NEJM, JAMA, NIH, FDA and peers. Each item links straight to the original report, with an AI summary for quick scanning.
- ReutersJul 22, 2026
Hair loss with GLP-1 drugs is rare, but real, studies find - Reuters
Not reported in abstract.
- ReutersJul 21, 2026
Novo sues Lilly, claiming misleading ads in weight-loss drug battle - Reuters
Not reported in abstract.
- MedPage TodayJul 20, 2026
Troubling Findings in Study of GLP-1 Compounders - MedPage Today
Not reported in abstract.
- ReutersJul 17, 2026
India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease - Reuters
Not reported in abstract.
- Mayo Clinic News NetworkJul 16, 2026
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment - Mayo Clinic News Network
Not reported in abstract.
- ReutersJul 15, 2026
Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters
Not reported in abstract.
- Harvard HealthJul 15, 2026
GLP-1 weight-loss drugs may lower the need for knee replacement - Harvard Health
Not reported in abstract.
- MedscapeJul 14, 2026
Semaglutide Linked to Rare Brain Illness - Medscape
This article discusses a potential association between semaglutide and a rare brain illness. The specific population affected and the dosage of semaglutide are not detailed in the abstract. The implications of this association for clinical practice are not fully explored.